Then the team used the cells from the surgery to grow billions of cancer - fighting
immune cells in the lab.
Not exact matches
«We suspected that the young are most vulnerable because of their immature
immune systems, but we didn't have a lot of hard evidence to show that before,» said study lead author Bo Hang, a Berkeley
Lab staff scientist who previously found that thirdhand smoke could lead to genetic mutations
in human
cells.
This new kind of approach to fighting blood cancers is truly personalized;
immune T -
cells are extracted from patients, genetically tinkered to home
in on an destroy cancerous
cells, multiplied
in a
lab, and then jolted back into the patient's body within about two weeks.
In 2011, the team was the first to report functional, lab - grown anal sphincters bioengineered from human cells that were implanted in immune - suppressed rodent
In 2011, the team was the first to report functional,
lab - grown anal sphincters bioengineered from human
cells that were implanted
in immune - suppressed rodent
in immune - suppressed rodents.
«Our
lab specializes
in developing novel genetic methodologies to study T
cell repertoires, but we had never applied this technology to study how the
immune system responds to an infection,» says Emanual Maverakis, M.D., associate professor of dermatology at the University of California, Davis School of Medicine.
«When we analyzed tissue samples
in the
lab, we found that exposing white fat to macrophage
cells from the
immune system inhibited the transformation.»
One approach would be to identify
immune cells in a tumour, grow them
in a
lab, and then infuse them back into the patient — a technique called adoptive
cell transfer.
In 1963, the couple moved to NYU to work as immunology research fellows in the lab of Baruj Benacerraf (who shared the Nobel Prize in Physiology or Medicine in 1980 for his work on the role of genetically determined, cell - surface structures in the regulation of immune reactions
In 1963, the couple moved to NYU to work as immunology research fellows
in the lab of Baruj Benacerraf (who shared the Nobel Prize in Physiology or Medicine in 1980 for his work on the role of genetically determined, cell - surface structures in the regulation of immune reactions
in the
lab of Baruj Benacerraf (who shared the Nobel Prize
in Physiology or Medicine in 1980 for his work on the role of genetically determined, cell - surface structures in the regulation of immune reactions
in Physiology or Medicine
in 1980 for his work on the role of genetically determined, cell - surface structures in the regulation of immune reactions
in 1980 for his work on the role of genetically determined,
cell - surface structures
in the regulation of immune reactions
in the regulation of
immune reactions).
In lab tests, the CpG - antigen package, at 300 nanometers in size, was absorbed 90 percent of the time by immune cells, the UI - led team report
In lab tests, the CpG - antigen package, at 300 nanometers
in size, was absorbed 90 percent of the time by immune cells, the UI - led team report
in size, was absorbed 90 percent of the time by
immune cells, the UI - led team reports.
To better determine the role of specific chemoattractants
in type III hypersensitivity, lead author Yoshishige Miyabe, MD, PhD, a research fellow
in Luster's
lab, used multiphoton intravital microscopy — an imaging technology pioneered for studies of
immune cell movements
in living animals by CIID investigator and co-author Thorsten Mempel, MD, PhD — to follow
in real time the development of IC - induced arthritis
in a mouse model of rheumatoid arthritis.
To investigate the relationship between temperature and
immune response, Iwasaki and an interdisciplinary team of Yale researchers spearheaded by Ellen Foxman, a postdoctoral fellow
in Iwasaki's
lab, examined the
cells taken from the airways of mice.
«Ultimately, the virus is suppressing the
immune system for its own benefit, and promoting the formation and proliferation of cancer
cells may be just a side effect of that,» says Sharon Kuss - Duerkop, PhD, research instructor working
in the
lab of CU Cancer Center investigator Dohun Pyeon, PhD.
Previous studies
in the
lab showed that once HCMV is inside the
cell, it quickly becomes latent by entering the
cell's nucleus and co-opting a cellular protein called Daxx — part of the intrinsic
immune system — to shut down its own replication, the process of reproducing its genetic material to make more copies of itself.
When they knocked two of these genes out of the bacterium's genome, it couldn't survive
in a
lab culture of
immune cells, they report
in the 26 May issue of Science.
Johannes Scheid, a student
in Nussenzweig's
lab, isolated it several years ago from an HIV - infected patient whose
immune system had an exceptional ability to neutralize HIV
in the blood by preventing the virus from infecting and destroying a specific type of
immune cells, called CD4
cells,
in patients.
By blocking a specific
cell signaling pathway
in lab animals, researchers reversed signs of chronic
immune activation, thereby boosting T -
cell recovery and viral suppression.
They tested 120 neural stem
cell lines
in the
lab for stability and robustness and
in animals for the capacity to engraft with minimal
immune rejection.
A solution, Cheng and his colleagues thought, could be to grow blood
cells in the
lab that were matched to each patient's own genetic material and thus could evade the
immune system.
An active area of investigation
in our
lab concerns the role of another cytokine produced mostly by innate
immune cells, the IL - 12 family member IL - 27.
The project began when a post-doc
in the Mullins
lab, Lillian Fritz - Laylin, collected a time - series of images of macrophage - like
immune cells in motion using Betzig's new microscope.
Rather than round up a patient's T
cells and re-engineer them
in a
lab to find cancer, this treatment harvests a class of
immune «helpers» called dendritic
cells.
Now, a new STEM
CELLS study from the labs of Qing - Ling Fu (Sun Yat - sen University, Guangzhou) and Zhongquan Qi (Xiamen University, Fujian, PR China) has described the effect of iPSC - MSCs on immune T cells in a relevant in vivo mouse m
CELLS study from the
labs of Qing - Ling Fu (Sun Yat - sen University, Guangzhou) and Zhongquan Qi (Xiamen University, Fujian, PR China) has described the effect of iPSC - MSCs on
immune T
cells in a relevant in vivo mouse m
cells in a relevant
in vivo mouse model.
Scientists from the Sundrud
lab have identified a normally small subset of
immune cells that may play a major role
in the development of Crohn's disease as well as steroid resistance associated with the disease.
In CAR T therapy, a person's own T
cells — disease - fighting
immune cells — are removed and sent to a
lab where they are genetically re-engineered to produce chimeric antigen receptors (CARs) on their surface.
With their deep expertise
in the biology of senescent
cells, the Campisi
lab will be focused on fundamental research into questions like how senescent
cells vary
in their susceptibility and resistance to
immune clearance (depending on factors like their tissues of residence or the pathway that led them into senescence); the targets and mechanisms used by NK
cells to clear senescent
cells; and why subsets of senescent
cells might persist when their similarly - situated neighbors are cleared out (and what might allow us to overcome that resistance).
The
lab is characterizing the quantity and quality (i.e. B and T
cell) of the
immune responses induced or generated by these DNA plasmids
in order to improve their ability to mediate virus neutralization and clearance.
Although progress toward harnessing the
immune system to attack tumors has been «enormous,» he said, his
lab and many others are seeing
in more and more studies —
in lab mice as well as patients — that «immuno - oncology» will not be as simple as stimulating T
cells to attack tumors.
Monoclonal antibodies are molecules, generated
in the
lab, that are designed to target cancer
cells and recruit
immune cells to attack.
His
lab has extensive experience evaluating and modulating T
cell responses to tumors and viruses, including introducing genes into T
cells to impart specificity and modulate function, designing strategies to overcome tolerance and enhance
in vivo activity, and developing mouse models that more accurately model human
immune responses to candidate vaccines.
She joined Dr. Yu's and Dr. Lichterfeld's
labs in August 2015 as a Postdoctoral Fellow to study specifically HIV reservoir (s)
in different
immune cell types using HIV nucleotide sequence diversity as markers.
Indeed, the
lab found that small molecules enhancing Nurr1's function can robustly suppress neuroinflammation and expression of proinflammatory genes
in immune cells.
The research team also created a synthetic version of the virus
in a
lab and found that toying with Tat completely outside of a host
immune cell could also switch it on and off, building on a study published last year which concluded that latency was «hard - wired» into the virus.
Important reports from the Weiner
lab include the first DNA vaccine studied for HIV as well as for cancer
immune therapy of cutaneous T
cell lymphoma, the early development of DNA encoded genetic adjuvants, including IL - 12, advances
in gene optimization, and advances
in electroporation technologies resulting
in improved gene delivery.
However,
in a 2014 study, Dr. Sulzer's
lab demonstrated that dopamine neurons (those affected by Parkinson's disease) are vulnerable because they have proteins on the
cell surface that help the
immune system recognize foreign substances.
In addition to checkpoint blockade antibodies, the editors also pointed to recent advances in adoptive cell therapy — removing a patient's immune cells, engineering them in the lab, and then re-infusing them back into the patient to fight cance
In addition to checkpoint blockade antibodies, the editors also pointed to recent advances
in adoptive cell therapy — removing a patient's immune cells, engineering them in the lab, and then re-infusing them back into the patient to fight cance
in adoptive
cell therapy — removing a patient's
immune cells, engineering them
in the lab, and then re-infusing them back into the patient to fight cance
in the
lab, and then re-infusing them back into the patient to fight cancer.
While the cancer normally excludes
immune T -
cells, the Evans
lab discovered that modified vitamin D reprograms the cancer environment
in a way that may allow the Merck drug Keytruda ® to invade and destroy the tumor.
The
cell types involved
in diabetes — the beta and
immune cells — are being studied
in the culture dish, as well as transplanted into
lab animals.
His
lab demonstrated that neoantigens (mutated proteins unique to cancerous
cells) present
in most or all
cells within a tumor are much more likely to be effectively recognized by the
immune system.